Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Prognosis
Protein levels associated with remission, survival
December 28th, 2004
Call it the immune system's version of urban combat. University of Florida (UF) researchers have identified a protein linked to remission in patients who have undergone bone marrow transplantation for blood-borne cancers such as leukemia or lymphoma. Known as interleukin-12, or IL-12, the protein's role in the body's hunt for insurgent cancer cells has yet to be fully defined, but study findings presented at the meeting of the American Society of Hematology in San Diego show patients with high levels soon after transplantation were twice as likely to survive as those with low levels. The protein also may give doctors the ability to accurately assess a cancer patient's...
Source: Cancer Weekly (2004-12-28)
|
